Navigation Links
Accuray Announces Results for First Quarter Fiscal 2012
Date:11/8/2011

60; 25,247Gross Profit MarginAccuray Q1'11Tomo Q1'11CombinedProducts62.4%45.5%52.2%Services33.5%(47.1%)(1.8%)Other(27.8%)-(27.8%)Total47.9%16.1%30.9%Operating ExpensesAccuray Q1'11Tomo Q1'11CombinedSelling and Marketing$
7,760$
7,255$   15,015Research and Development8,0478,22816,275General and Administrative8,5597,13515,694Total$
24,366$
22,618$   46,984Net Loss Attributable to StockholdersAccuray Q1'11Tomo Q1'11CombinedLoss From Operations$
(6,129)$
(15,608)$  (21,737)Other Income1,6161,8773,493Provision For Income Taxes12747174Noncontrolling Interest(1,842)(1,842)Net Loss Attributable to Stockholders$
(4,640)$
(11,936)$  (16,576)Net Loss Per Share - Basic and Diluted$
(0.08)$
(0.23)$
(0.24)Weighted Average Common Shares outstanding - Basic and Diluted58,66751,93467,780(A)(A) Represents weighted average common shares outstanding used to compute our basic and diluted net loss per share as disclosed in our Form 10Q for the quarter ended September 30, 2010, adjusted to reflect the acquisition of TomoTherapy as if it occurred on July 1, 2010.


'/>"/>
SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
2. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
3. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
4. Accuray Reschedules Announcement of Results for First Quarter of Fiscal 2009
5. Accuray Postpones Release of First Quarter Fiscal 2009 Results
6. Accuray Achieves Milestone of 150th CyberKnife System Installed Worldwide
7. Accuray Incorporateds CEO to Speak at 27th Annual JP Morgan Healthcare Conference
8. Accuray Incorporated to Report Second Quarter Fiscal Year 2009 Financial Results
9. 10 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service
10. Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference
11. Accuray Incorporated to Present at Robert Baird 2009 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... According to Jeff Howell, Partner of Nidea ... new development in Downtown Toronto is expanding at a ... 755 storeys of new development last week (including three ... dominating the Toronto skyline for the foreseeable future in ... for new development. , As the Toronto city council ...
(Date:9/15/2014)... phase transitionsthink solid, liquid, and gasbut much ... drops. If phase transitions occur at the ... subtle fluctuations can dramatically transform a material. ... of Energy,s Brookhaven National Laboratory and Stony ... of absolute zero to isolate and probe ...
(Date:9/15/2014)... 16, 2014 Cancer Immunotherapy ... Adoptive T-cell Therapies is a new market research ... the three principal types of therapeutics that have ... in cancer immunotherapy (which is often called "immuno-oncology") ... and Adoptive cellular immunotherapy. , The regular ...
(Date:9/15/2014)... Calif. , Sept. 15, 2014  FlexTech ... (RFP) for flexible, printed product demonstrators (demos) and ... two-stage RFP process with pre-proposals due on October ... 2015.  Funds for proposals ultimately selected are provided ... have a significant cost share by the proposing ...
Breaking Biology Technology:ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 2ITRA Global Reports Downtown Toronto Real Estate Development is in High Gear 3Elusive quantum transformations found near absolute zero 2Elusive quantum transformations found near absolute zero 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 4Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 5FlexTech Alliance Issues 2015 Request for Proposals in Flexible, Printed Electronics 2
... (Nasdaq: MNKD ), focused on discovering, developing and,commercializing ... present at the UBS Global Life Sciences Conference on ... Hyatt Hotel in New York, NY. Interested parties ... of the,presentation in the Investor Relations section of the ...
... Sept. 18 InterMune, Inc.,(Nasdaq: ITMN ) today ... other conditions, 3,000,000 shares of its common stock in ... underwriters,a 30-day option to purchase up to an additional ... All of the shares in the offering,will be sold ...
... Sept. 18 /PRNewswire-FirstCall/-- Biodel Inc. (Nasdaq:,BIOD) today ... program,at the 43rd Scientific Sessions of the ... VIAject(TM) Phase II meal study data ... entitled, "Pharmacokinetics and pharmacodynamics of,insulin VIAject(TM), insulin ...
Cached Biology Technology:InterMune Announces Proposed Public Offering of Common Stock 2Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting 2Biodel Inc. Announces VIAject(TM) Phase II Meal Study Data at the 2007 European Association for the Study of Diabetes Meeting 3
(Date:9/16/2014)... new school year, a new football season and another ... September, SpaceX,s Dragon spacecraft is scheduled to blast off ... part of the company,s fourth contracted mission to the ... third suite of research investigations sponsored by the Center ... the role of managing the U.S. National Laboratory on ...
(Date:9/16/2014)... of the Keystone XL pipeline (KXL) would likely increase ... and researchers surveyed by the non-profit organization Near Zero. ... The Climate Impact," and includes both supporters and opponents ... of oil sands could lead to significantly higher greenhouse ... how markets respond. , "This report examines three ...
(Date:9/16/2014)... this week, its Government could face an uphill challenge ... research has revealed. , The University of Nottingham Shale ... gas extraction in the UK since March 2012 and ... are the least supportive of fracking. , Professor Sarah ... of Geography, said: "The clear move against shale gas ...
Breaking Biology News(10 mins):CASIS research set for launch aboard SpaceX mission to space station 2CASIS research set for launch aboard SpaceX mission to space station 3Keystone XL would likely raise oil sands production and greenhouse gas emissions 2Scottish people most sceptical on fracking, survey shows 2Scottish people most sceptical on fracking, survey shows 3
... is an integral part of modern cancer treatment, but ... ability of anticancer drugs to escape from the bloodstream ... Predicting chemotherapy,s efficacy could save thousands of individuals ... of the treatments. In a study published in ...
... Broad Institute of Harvard and MIT and Beth Israel ... of previously unrecognized mammalian genes that do not encode ... findings, presented in the February 1st advance online issue ... novel class of "large intervening non-coding RNAs" or "lincRNAs" ...
... of Juan de Fuca, which separates Washington state from ... toxic harmful algal blooms affecting the Washington and British ... conditions, toxic algal cells from an offshore "initiation site" ... they may trigger harmful algal blooms that ultimately force ...
Cached Biology News:New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome 2New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome 3Scientists uncover new class of non-protein coding genes in mammals with key functions 2Scientists uncover new class of non-protein coding genes in mammals with key functions 3'Hot spot' for toxic harmful algal blooms discovered off Washington coast 2
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
The DNA DipStick Kit is ideal for estimating nucleic acid concentrations and approximate yields. Works with ss- and ds-DNA, RNA, and oligonucleotides at concentrations as low as 0.1 ng/l....
... NEW HandyStep electronic from BRAND adds ... It is the only electronic, motor-driven ... syringe tips, including BRAND PD-Tip syringe ... Fisherbrand Dispenser Tips,and VWRbrand Combi-Syringes. Select ...
The pYES2 vector is designed for native expression of your protein of interest in S. cerevisiae. It contains the URA3 gene for selection in yeast and 2 origin for high-copy maintenance....
Biology Products: